Ankara Universitesi Teknokent
🇹🇷Turkey
Clinical Trials
8
Active:0
Completed:8
Trial Phases
2 Phases
Phase 3:3
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (62.5%)Phase 3
3 (37.5%)Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision
Phase 3
Completed
- Conditions
- Retinitis Pigmentosa
- First Posted Date
- 2023-04-05
- Last Posted Date
- 2023-04-05
- Lead Sponsor
- Ankara Universitesi Teknokent
- Target Recruit Count
- 80
- Registration Number
- NCT05800301
- Locations
- 🇹🇷
BioRetina, Ankara, Gölbaşı, Turkey
🇹🇷Ankara University Biotechnology Institute, Ankara, Türkiye, Turkey
🇹🇷Umut Arslan, Ankara, Turkey
Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation
Phase 3
Completed
- Conditions
- Toxic Optic NeuropathyMagnetic Field ExposureStem Cell Tyrosine Kinase 1 Y842XMethanol Poisoning
- First Posted Date
- 2021-05-07
- Last Posted Date
- 2021-05-10
- Lead Sponsor
- Ankara Universitesi Teknokent
- Target Recruit Count
- 18
- Registration Number
- NCT04877067
- Locations
- 🇹🇷
Ankara University Biotechnology Institute, Ankara, Türkiye, Turkey
🇹🇷Umut Arslan, Ankara, Turkey
Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma
Not Applicable
Completed
- Conditions
- Retinitis Pigmentosa
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Ankara Universitesi Teknokent
- Target Recruit Count
- 60
- Registration Number
- NCT04252534
Management of Deep Retinal Capillary Ischemia by Electromagnetic Stimulation and Platelet- Rich Plasma
Not Applicable
Completed
- Conditions
- Paracentral Acute Middle MaculopathyAcute Macular NeuroretinopathyDeep Retinal Capillary Ischemia
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Ankara Universitesi Teknokent
- Target Recruit Count
- 28
- Registration Number
- NCT04242719
- Locations
- 🇹🇷
Ankara University Biotechnology Institute, Ankara, Türkiye, Turkey
Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa
Not Applicable
Completed
- Conditions
- Retinitis Pigmentosa
- First Posted Date
- 2020-01-23
- Last Posted Date
- 2020-01-23
- Lead Sponsor
- Ankara Universitesi Teknokent
- Target Recruit Count
- 48
- Registration Number
- NCT04238858
- Locations
- 🇹🇷
Ankara University Biotechnology Institute, Ankara, Türkiye, Turkey
- Prev
- 1
- 2
- Next
News
No news found